In conclusion, this large single centre analysis showed a higher precursor lesion detection rate as well as a lower CRC incidence for individuals with LS caused by a gPV in MSH6 or PMS2, suggesting the potential for extended surveillance intervals for these patients. This evidence concerns the gene MSH6 and colorectal carcinoma.